Vessela Vassileva

1.3k total citations
21 papers, 1.1k citations indexed

About

Vessela Vassileva is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Vessela Vassileva has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Reproductive Medicine. Recurrent topics in Vessela Vassileva's work include Ovarian cancer diagnosis and treatment (6 papers), HER2/EGFR in Cancer Research (4 papers) and Chemical Synthesis and Analysis (3 papers). Vessela Vassileva is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), HER2/EGFR in Cancer Research (4 papers) and Chemical Synthesis and Analysis (3 papers). Vessela Vassileva collaborates with scholars based in United Kingdom, Canada and India. Vessela Vassileva's co-authors include Micheline Piquette‐Miller, Christine Allen, R. Barbara Pedley, Vijay Chudasama, Stephen Caddick, James R. Baker, E. Robinson, João P. M. Nunes, Mark E. B. Smith and William Chapman and has published in prestigious journals such as Chemical Communications, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

Vessela Vassileva

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vessela Vassileva United Kingdom	14	466	404	199	169	159	21	1.1k
Marilynn Vetzel United States	17	483 1.0×	540 1.3×	324 1.6×	69 0.4×	66 0.4×	28	1.3k
Mathew Robson United Kingdom	18	153 0.3×	451 1.1×	198 1.0×	59 0.3×	92 0.6×	30	901
Mariana Scaranti Brazil	9	323 0.7×	269 0.7×	58 0.3×	73 0.4×	70 0.4×	25	832
Li Ding China	15	242 0.5×	434 1.1×	64 0.3×	56 0.3×	129 0.8×	38	877
Heather J. Bax United Kingdom	19	231 0.5×	403 1.0×	275 1.4×	448 2.7×	44 0.3×	39	1.2k
Lian Li China	17	314 0.7×	467 1.2×	93 0.5×	178 1.1×	236 1.5×	40	1.0k
Abhijit Aithal United States	12	372 0.8×	428 1.1×	115 0.6×	218 1.3×	163 1.0×	23	809
Manuela Porru Italy	27	693 1.5×	1.4k 3.4×	95 0.5×	150 0.9×	303 1.9×	48	2.1k
Renquan Lu China	21	405 0.9×	625 1.5×	45 0.2×	121 0.7×	343 2.2×	62	1.2k
Adnan O. Abu‐Yousif United States	15	270 0.6×	268 0.7×	161 0.8×	164 1.0×	95 0.6×	35	1.1k

Countries citing papers authored by Vessela Vassileva

Since Specialization

Citations

This map shows the geographic impact of Vessela Vassileva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vessela Vassileva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vessela Vassileva more than expected).

Fields of papers citing papers by Vessela Vassileva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vessela Vassileva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vessela Vassileva. The network helps show where Vessela Vassileva may publish in the future.

Co-authorship network of co-authors of Vessela Vassileva

This figure shows the co-authorship network connecting the top 25 collaborators of Vessela Vassileva. A scholar is included among the top collaborators of Vessela Vassileva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vessela Vassileva. Vessela Vassileva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vassileva, Vessela, Chris Barnes, Justyna M. Przystal, et al.. (2021). Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging. Biomedicines. 9(7). 811–811. 9 indexed citations

Vassileva, Vessela, Stephen M. Stribbling, Chris Barnes, et al.. (2019). Evaluation of apoptosis imaging biomarkers in a genetic model of cell death. EJNMMI Research. 9(1). 18–18. 10 indexed citations

Mohammad, Goran H., Vessela Vassileva, Pilar Acedo, et al.. (2019). Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer. Cancers. 11(9). 1372–1372. 49 indexed citations

Parhizkar, Maryam, A. H. Harker, Richard J. Browning, et al.. (2017). Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment. International Journal of Nanomedicine. Volume 12. 3913–3926. 36 indexed citations

Robinson, E., João P. M. Nunes, Vessela Vassileva, et al.. (2017). Pyridazinediones deliver potent, stable, targeted and efficacious antibody–drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody. RSC Advances. 7(15). 9073–9077. 63 indexed citations

Browning, Richard J., Maryam Parhizkar, A. H. Harker, et al.. (2017). Ultrasound enhanced delivery of cisplatin loaded nanoparticles. The Journal of the Acoustical Society of America. 141(5_Supplement). 3459–3459. 2 indexed citations

Stahl, Thomas, Kealan J. Fallon, Peter C. Johnson, et al.. (2017). Tunable Semiconducting Polymer Nanoparticles with INDT-Based Conjugated Polymers for Photoacoustic Molecular Imaging. Bioconjugate Chemistry. 28(6). 1734–1740. 28 indexed citations

Nunes, João P. M., Vessela Vassileva, E. Robinson, et al.. (2017). Use of a next generation maleimide in combination with THIOMAB™ antibody technology delivers a highly stable, potent and near homogeneous THIOMAB™ antibody-drug conjugate (TDC). RSC Advances. 7(40). 24828–24832. 47 indexed citations

Vassileva, Vessela, Vineeth Rajkumar, Mathew Robson, et al.. (2015). Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer. Journal of Nuclear Medicine. 56(8). 1239–1245. 14 indexed citations

10.

Nunes, João P. M., Maurício Morais, Vessela Vassileva, et al.. (2015). Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody–drug conjugate (ADC). Chemical Communications. 51(53). 10624–10627. 100 indexed citations

11.

Coward, Jermaine, Hagen Kulbe, Probir Chakravarty, et al.. (2011). Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. Clinical Cancer Research. 17(18). 6083–6096. 313 indexed citations

12.

Vassileva, Vessela, Christine Allen, & Micheline Piquette‐Miller. (2008). Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer. Molecular Cancer Therapeutics. 7(3). 630–637. 63 indexed citations

13.

Vassileva, Vessela & Micheline Piquette‐Miller. (2008). Ovarian tumour repopulation in response to sustained and intermittent paclitaxel therapy.. UCL Discovery (University College London). 1 indexed citations

14.

Vassileva, Vessela, Eduardo H. Moriyama, Raquel De Souza, et al.. (2008). Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging. British Journal of Cancer. 99(12). 2037–2043. 42 indexed citations

15.

Vassileva, Vessela, Justin Grant, Raquel De Souza, Christine Allen, & Micheline Piquette‐Miller. (2007). Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. Cancer Chemotherapy and Pharmacology. 60(6). 907–914. 57 indexed citations

16.

Ho, Emmanuel A., et al.. (2006). PI-18Impact of localized, sustained delivery of paclitaxel on the in vitro and in vivo regulation of P-glycoprotein. Clinical Pharmacology & Therapeutics. 79(2). P11–P11. 1 indexed citations

17.

Ho, Emmanuel A., Vessela Vassileva, Christine Allen, & Micheline Piquette‐Miller. (2005). In vitro and in vivo characterization of a novel biocompatible polymer–lipid implant system for the sustained delivery of paclitaxel. Journal of Controlled Release. 104(1). 181–191. 58 indexed citations

18.

Hartmann, Georgy, Vessela Vassileva, & Micheline Piquette‐Miller. (2005). IMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICE. Drug Metabolism and Disposition. 33(6). 820–828. 59 indexed citations

19.

Vassileva, Vessela, et al.. (2004). Apoptotic and growth regulatory genes as mutational targets in mismatch repair deficient endometrioid adenocarcinomas of young patients. Oncology Reports. 11(4). 931–7. 9 indexed citations

20.

Vassileva, Vessela, et al.. (2002). Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability.. PubMed. 62(14). 4095–9. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact